Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofDobutamine Injectionfrom Surat, Gujarat, India. Dobutamine Injection used in the treatment of cardiogenic shock and severe heart failure.
Tags: Dobutamine Injection manufacturer, Dobutamine Injection exporter,Dobutamine Injection supplier, and Dobutamine Injection, whogmp approved Dobutamine Injectionmanufacturer and supplier, Dobutamine Injection distributor, Dobutamine Injectionshipper, Dobutamine Injection 50 ml Dobutamine Injection 50 mlsupplier,Dobutamine Injection 50 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceDobutamine Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Optimized Cardiac SupportDobutamine Injection is essential for rapidly improving cardiac output in adults experiencing cardiac decompensation. Its fast-acting formulation allows healthcare professionals to quickly address acute heart failure, stabilizing patients when immediate intervention is required. The high purity and sterile nature make it a reliable choice for critical care.
Strict Hospital Use and Storage RequirementsThis medication is recommended strictly for use in hospital and clinical environments, ensuring it is administered by trained medical personnel. To maintain its efficacy and safety profile, the injection should be stored below 25C and protected from light. Its single-use, preservative-free design further reduces contamination risks.
FAQ's of Dobutamine Injection:
Q: How is Dobutamine Injection administered to patients?
A: Dobutamine Injection is administered intravenously (IV) by healthcare professionals in a hospital or clinical setting. The dosage and duration are determined by a physician based on the patient's specific medical needs.
Q: What is the main benefit of using Dobutamine Injection during cardiac decompensation?
A: The primary benefit is its rapid action in increasing cardiac output, helping to stabilize patients experiencing acute heart failure or cardiac decompensation. This swift intervention can support vital organ perfusion in critical situations.
Q: When should Dobutamine Injection be used?
A: This injection is indicated for short-term treatment when patients experience cardiac decompensation due to reduced heart function, typically in acute care or emergency cardiology settings.
Q: Where should Dobutamine Injection be stored prior to use?
A: The vials must be stored below 25C and protected from light, in accordance with the instructions, to preserve the medication's integrity and effectiveness.
Q: What precautions must be taken during the use of Dobutamine Injection?
A: As Dobutamine Injection is preservative-free, any unused portion must be discarded after a single use. It should only be used under direct supervision of medical personnel to mitigate any potential adverse effects.
Q: Who is Dobutamine Injection suitable for?
A: This medication is suitable for adult patients who require short-term cardiac support and should only be administered in hospital or clinical environments.